|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
IMMUNOGLOBULIN IGG
Test CodeLAB71
CPT Codes
82784
Preferred Specimen
5.0 mL Gold SST
Minimum Volume
2.0 mL
Other Acceptable Specimens
7.0 mL Red Top Tube
Transport Temperature
Refrigerated
Methodology
Immunoturbidimetric
Setup Schedule
Set Up:Daily Report Available:Same day
Reference Range
Age (Female/Male) | Reference Range |
---|---|
<1M | 251-906 mg/dL |
1M-2M | 206-601 mg/dL |
2M-3M | 176-581 mg/dL |
3M-6M | 215-704 mg/dL |
6M-2Y | 345-1213 mg/dL |
2Y-3Y | 441-1135 mg/dL |
3Y-8Y | 463-1280 mg/dL |
8Y-10Y | 608-1572 mg/dL |
>10Y | 622-1593 mg/dL |
Clinical Significance
IgG molecules are monomers composed of two light chains (kappa and lambda) and two gamma heavy chains.1 Approximately 80% of serum immunoglobulin is IgG; its main task lies in defense against microorganisms, direct neutralization of toxins, and induction of complement fixation. IgG is the only immunoglobulin that can cross the placental barrier and provide passive immune protection for the fetus and newborn. This protection gradually catabolizes until the infants own immunological system begins to function at about six months of age. Near adult levels are reached by 18 months. Polyclonal IgG increases may be present in systemic lupus erythematosis, chronic liver diseases (infectious hepatitis and Laennecs cirrhosis), infectious diseases, and cystic fibrosis. Monoclonal IgG increases in IgG myeloma. Decreased synthesis of IgG is found in congenital and acquired immunodeficiency diseases and selective IgG subclass deficiencies, such as Bruton type agammaglobulinemia. Increased IgG loss is seen in protein-losing enteropathies, nephrotic syndrome, and through the skin from burns. Increased IgG metabolism is found in Wiskott-Aldrich syndrome, myotonic dystrophy, and with anti-immunoglobulin antibodies.
Performing Laboratory
GBMC Chemistry